Biotechnology
Asieris' APL-1501 Approved for Phase I Clinical Trial in Australia
SHANGHAI, Oct. 29, 2020 /PRNewswire/ -- Asieris Pharmaceuticals, a China-based biotech company specializing in the development and commercialization of new drugs for the treatment of genitourinary tumors and related diseases, today announced that Australian regulatory authorities have approved it...
MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition
AGC Biologics Now Provides End-to-End Cell and Gene Therapy CDMO Services SEATTLE, Oct. 28, 2020 /PRNewswire/ -- After its parent company AGC Inc. acquired 100% of the shares of MolMed S.p.A. onSeptember 30, 2020, AGC Biologics announced that MolMed's entity name has been changed to AGC Biologic...
TVM Capital Life Science Announces Substantially Oversubscribed US$478 Million Final Closing of TVM Life Science Innovation II, largest fund in the firm's history
- The Fund continues the proven "Project Focused Company" investment strategy for early-stage drug development candidates - In addition, the Fund continues to invest in late-stage clinical biopharmaceutical companies, medical device companies and diagnostic companies MUNICH and MONTREAL, Oct. 27...
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of MDM2-p53 Inhibitor APG-115 in Combination with Immunotherapy for the Treatment of Patients with Advanced Liposarcoma or other Advanced Solid Tumors in China
SUZHOU, China and ROCKVILLE, Md., Oct. 27, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Eva...
CStone and EQRx Enter Global Strategic Partnership for Two Immune Checkpoint Inhibitors: sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1)
* CStone to out-license to EQRx exclusive rights to two late-stage immuno-oncology assets for development and commercialization outside ofGreater China * Agreement provides a pathway to bring CStone's sugemalimab (anti-PD-L1) and CS1003 (anti-PD-1) to global patient communities by partnering ...
Sai Life Sciences to significantly expand biology capabilities at its integrated R&D campus
HYDERABAD, India, Oct. 26, 2020 /PRNewswire/ -- Sai Life Sciences, one of
India's fastest growing Contract Research, Development & Manufacturing
Organizations
RhoVac Participates in BIO Europe Digital
LUND, Sweden, Oct. 26, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today that it is participating this week in the partnering event BIO Europe 2020 Digital. This week the digital version of the massive pharmaceutical partnering conference BIO Europe is held with participation from RhoVac...
TUV Rheinland Announces the Opening of its NABL Accredited Biomaterial and EMC Testing Laboratories
VISAKHAPATNAM, India, Oct. 23, 2020 /PRNewswire/ -- TUV Rheinland, a global leader in independent technical services announced the opening of its Biomaterial and EMC (Electro Magnetic Compatibility) Testing Laboratories located at Andhra Pradesh MedTech Zone (AMTZ), Visakhapatnam, Andhra Pradesh....
FDA Awards $1.1M Contract to CUBRC and EpiVax for Validation of New Immunoinformatic Tool for Prospective Immunogenicity Assessment of Peptide Drugs and Their Impurities
PROVIDENCE, Rhode Island, Oct. 22, 2020 /PRNewswire/ -- EpiVax, Inc. ("EpiVax") and CUBRC, Inc. ("CUBRC") announced today that they have been awarded a two-year,$1.1 million contract from the Office of Generic Drugs (OGD) in the Center of Drug Evaluation and Research (CDER) of the Food and Drug ...
Connect Biopharma to Present Additional Positive Results from the Phase 1b Study of CBP-201 for Patients with Moderate-to-Severe Atopic Dermatitis (AD) at EADV Virtual Meeting
SAN DIEGO and TAICANG, SUZHOU, China, Oct. 22, 2020 /PRNewswire/ -- Connect Biopharma, a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune and inflammatory diseases, today announced it wil...
Priority Review Granted to Ascentage Pharma's New Drug Application for Olverembatinib (HQP1351), the First Third-Generation BCR-ABL Inhibitor in China
SUZHOU, China and ROCKVILLE, Md., Oct. 21, 2020 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the Center for Drug Eva...
Cyclica to use Excelra's GOSTAR Database to develop AI & ML based Deep Learning Algorithm for Drug Target Identification
HYDERABAD, India and TORONTO, Oct. 21, 2020 /PRNewswire/ -- Excelra
Nanoform initiates GMP campaign for first-in-human trial of nanoformed drug by year end - ahead of schedule
HELSINKI, Finland, Oct. 21, 2020 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform "), an innovative nanoparticle medicine enabling company will, in the fourth quarter of 2020, start the first ever human trial of a drug candidate nanoformed using Nanoform's proprietary CESS® technology. Dosing will ...
Key patent granted for Isla101 in Brazil
MELBOURNE, Australia, Oct. 20, 2020 /PRNewswire/ -- Isla Pharmaceuticals, a US-based company focused on rational repurposing of molecules for the treatment or prevention of viruses is pleased to announce that a key patent relating to the Company's lead program, Isla101 has been granted by the Bra...
analytica 2020 - free entry from the computer
Messe München and LUMITOS stage the largest virtual event of the year for the lab industry BERLIN, Oct. 16, 2020 /PRNewswire/ -- analytica, the world's leading trade fair for laboratory technology, analysis and biotechnology, will take place completely virtually in 2020. Visitors and exhibitors ...
Kazia Executes Agreement To Commence GBM Agile Pivotal Study
SYDNEY, Oct. 16, 2020 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has executed a definitive agreement with the Global Coalition for Adaptive Research (GCAR) to commence Kazia's participat...
AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions
SEATTLE, Oct. 15, 2020 /PRNewswire/ -- AGC Biologics, a leading global biopharmaceutical contract development and manufacturing organization (CDMO), has announced a leadership update atthe United States and Copenhagen facilities. The changes are being made to strengthen the strategic development ...
Thrive Bioscience Launches the CellAssist to Provide Imaging, Analytics, and Documentation for Reproducible Cell Culture
WAKEFIELD, Massachusetts, Oct. 15, 2020 /PRNewswire/ -- Thrive Bioscience introduces the CellAssist® which enables cell culture researchers to image, analyze, and document all cells, plates, reagents, and workflow details in a centralized database. The CellAssist was developed by Thrive Biosci...
Antengene Announces Collaboration with WuXi Biologics to Advance the Development of Innovative Oncology Medicines
SHANGHAI, Oct. 10, 2020 /PRNewswire/ -- Antengene Corporation, a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, and WuXi Biologics ("WuXi Bio") (2269.HK) a...
Innovent Announces the Appointment of Dr. Yong Jun Liu as the President of the Group
SAN FRANCISCO and SUZHOU, China, Oct. 15, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...
Week's Top Stories
Most Reposted
LINKDOOD Breaks Language Barriers, Ushering a New Era for Cross-Border Romance
[Picked up by 326 media titles]
2024-04-29 06:00Multiple achievements made in China-Hungary BRI conference
[Picked up by 309 media titles]
2024-05-03 06:59Dow showcases circular and innovative materials science solutions and industry collaborations at Chinaplas 2024
[Picked up by 293 media titles]
2024-04-30 10:11Xinhua president, Hungarian economy minister vow to bolster media cooperation
[Picked up by 280 media titles]
2024-05-03 06:25Puyuan Fashion Resort 2024: A Grand Unveiling of Global Trends and Local Heritage
[Picked up by 269 media titles]
2024-04-28 09:39